Semanteon Capital Management LP Purchases New Position in U.S. Physical Therapy, Inc. (NYSE:USPH)

Semanteon Capital Management LP purchased a new stake in U.S. Physical Therapy, Inc. (NYSE:USPH) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 8,236 shares of the company’s stock, valued at approximately $767,000.

Other institutional investors have also bought and sold shares of the company. Quantbot Technologies LP acquired a new position in U.S. Physical Therapy in the third quarter worth $82,000. Park Avenue Securities LLC acquired a new position in U.S. Physical Therapy in the third quarter worth $232,000. International Assets Investment Management LLC boosted its stake in U.S. Physical Therapy by 9,269.0% in the fourth quarter. International Assets Investment Management LLC now owns 2,717 shares of the company’s stock worth $253,000 after purchasing an additional 2,688 shares in the last quarter. HighTower Advisors LLC boosted its stake in U.S. Physical Therapy by 47.2% in the third quarter. HighTower Advisors LLC now owns 2,773 shares of the company’s stock worth $257,000 after purchasing an additional 889 shares in the last quarter. Finally, Channing Capital Management LLC acquired a new position in U.S. Physical Therapy in the third quarter worth $286,000.

U.S. Physical Therapy Trading Up 0.3 %

Shares of USPH stock traded up $0.35 on Friday, reaching $100.73. 30,485 shares of the stock were exchanged, compared to its average volume of 69,594. The stock has a 50 day moving average price of $105.04 and a 200 day moving average price of $95.35. The stock has a market cap of $1.52 billion, a PE ratio of 74.58, a P/E/G ratio of 4.92 and a beta of 1.39. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.28 and a quick ratio of 2.28. U.S. Physical Therapy, Inc. has a one year low of $78.08 and a one year high of $124.11.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings data on Wednesday, February 28th. The company reported $0.59 EPS for the quarter, beating analysts’ consensus estimates of $0.57 by $0.02. The business had revenue of $154.80 million during the quarter, compared to the consensus estimate of $150.24 million. U.S. Physical Therapy had a return on equity of 8.52% and a net margin of 4.67%. The firm’s revenue was up 9.6% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.58 earnings per share. Equities research analysts forecast that U.S. Physical Therapy, Inc. will post 2.77 EPS for the current fiscal year.

U.S. Physical Therapy Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, April 5th. Investors of record on Tuesday, March 12th were issued a $0.44 dividend. This represents a $1.76 dividend on an annualized basis and a yield of 1.75%. The ex-dividend date was Monday, March 11th. This is an increase from U.S. Physical Therapy’s previous quarterly dividend of $0.43. U.S. Physical Therapy’s dividend payout ratio is currently 130.37%.

Analyst Upgrades and Downgrades

USPH has been the subject of a number of recent research reports. JPMorgan Chase & Co. boosted their target price on U.S. Physical Therapy from $99.00 to $117.00 and gave the stock an “overweight” rating in a research report on Wednesday, March 13th. Barrington Research boosted their target price on U.S. Physical Therapy from $120.00 to $122.00 and gave the stock an “outperform” rating in a research report on Friday, March 1st. Finally, StockNews.com upgraded U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Monday, March 18th. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $125.67.

Insider Activity at U.S. Physical Therapy

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 2,629 shares of the stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $104.39, for a total value of $274,441.31. Following the completion of the sale, the chief operating officer now directly owns 6,902 shares in the company, valued at $720,499.78. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other U.S. Physical Therapy news, COO Graham D. Reeve sold 2,629 shares of the stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $104.39, for a total value of $274,441.31. Following the completion of the sale, the chief operating officer now directly owns 6,902 shares in the company, valued at $720,499.78. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Carey P. Hendrickson sold 1,800 shares of the stock in a transaction dated Wednesday, March 13th. The stock was sold at an average price of $107.28, for a total value of $193,104.00. Following the completion of the sale, the chief financial officer now owns 21,186 shares of the company’s stock, valued at $2,272,834.08. The disclosure for this sale can be found here. Over the last quarter, insiders sold 10,829 shares of company stock worth $1,141,535. 1.80% of the stock is owned by insiders.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.